2020 annual financial data
Revolution Medicines 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -232.8%.
Operating income was -110,697,000 USD and net income was -108,159,000 USD.
Operating cash flow was -100,064,000 USD.
Get free Revolution Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,983,000 USD
- Operating income
- -110,697,000 USD
- Net income
- -108,159,000 USD
- Operating cash flow
- -100,064,000 USD